Search Results for 'covid 19'
- On this site
- On the Global Health Network
Grand Challenges ICODA
...COVID-19 Data Alliance (ICODA) and the Grand Challenges initiative are supporting ten global project...
https://globalhealthdatascience.tghn.org/data-science-exemplars/grand-challenges-icoda/
Universidad de La Sabana (and hospital)
https://sitefinder.tghn.org/sites/universidad-de-la-sabana-and-hospital/
Shaukat Khanum Memorial Cancer Hospital and Research Centre
https://sitefinder.tghn.org/sites/shaukat-khanum-memorial-cancer-hospital-and-research-centre/
The Gambia
...COVID-19, the MRC Unit The Gambia Clinical Services Department has developed and shared th...
https://alerrt.tghn.org/alerrt-ccp/the-gambia/
Guidance: Monitoring places of detention through the covid-19 pandemic
https://wephren.tghn.org/articles/guidance-monitoring-places-detention-through-covid-19-pandemic/
UK-PHRST COVID-19 Outbreak Support
...COVID-19 seroprevalence study
Read more: UK Public Health Rapid Support Team COVID-19 Respon...
https://uk-phrst.tghn.org/covid-19/covid-19-response/
Clinical Management
...COVID-19 critical care: Understanding and application University of Edinburgh and Royal College...
https://coronavirus.tghn.org/research-resources/training-resources/clinical-management/
CEPI welcomes announcement from Pfizer / BioNTech of positive interim data from Phase III trial of COVID-19 vaccine candidate
...COVID-19 achieved success in the first interim analysis from the phase 3 COVID-19 vaccine trial.
https://cepi-tr.tghn.org/articles/cepi-welcomes-announcement-pfizer-biontech-positive-interim-data-phase-iii-trial-covid-19-vaccine-candidate/
Apixaban, an orally available anticoagulant, inhibits SARS-CoV-2 replication and its major protease in a non-competitive way
...19 (COVID-19) is associated with coagulopathy. Anticoagulants, such as low-molecular-weight heparin,...
https://coronavirus.tghn.org/articles/apixaban-orally-available-anticoagulant-inhibits-sars-cov-2-replication-and-its-major-protease-non-competitive-way/
Efficacy Endpoints in COVID-19 Vaccine Trials: SARS-CoV-2 Infection
https://cepi-tr.tghn.org/articles/efficacy-endpoints-covid-19-vaccine-trials-sars-cov-2-infection/
Resposta dos países lusófonos à COVID-19
...COVID-19
Este espaço surgiu em resposta ao interesse dos participantes do Webinar T...
https://coronavirus.tghn.org/regional-response/pt-covid/
Africa COVID-19 Webinars
...COVID-19 in Africa.
Africa COVID-19 Resources
Africa COVID-19 Mitigation
Africa COVID-19 ...
https://coronavirus.tghn.org/regional-response/africa-ncov/africa-covid-19-webinars/
Preparing communities to receive persons recently suspected or diagnosed with COVID-19
...COVID-19 was reported in Uganda, there are increasing number of reports of acts of ...
https://globalresearchnurses.tghn.org/community/blogs/post/600413/2022/08/preparing-communities-to-receive-persons-recen/
Covid-19 epidemiological panel in vulnerable urban territories: a Brazilian case
Global Health Training Centre
//globalhealthtrainingcentre.tghn.org/elearning/education/tools-addressing-public-health-emergencies-context-civil-society/covid-19-epidemiological-panel-vulnerable-urban-territories-brazilian-case/
COVID-19 Research Sites
...COVID-19. In response to the pandemic, SiteFinder has created a specific disease listing for COVID-1...
https://sitefinder.tghn.org/covid-19-research-sites/
Uganda: CCP Protocol
...COVID-19.
Specific aims
Describe the clinical features of COVID-19 in Uganda and monit...
https://alerrt.tghn.org/alerrt-ccp/uganda/uganda-ccp-protocol/
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
...COVID-19.
https://isaric.tghn.org/articles/remdesivir-adults-severe-covid-19-randomised-double-blind-placebo-controlled-multicentre-trial/
Study Protocols and materials
...COVID-19, this team of researchers have developed the following protocols and study materials to fit...
https://coronavirus.tghn.org/resource-sharing/health-systems-study/resources/